GE HealthCare Technologies Inc. $GEHC is Arvin Capital Management LP’s 8th Largest Position

Arvin Capital Management LP decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 303,912 shares of the company’s stock after selling 60,356 shares during the period. GE HealthCare Technologies accounts for about 4.7% of Arvin Capital Management LP’s portfolio, making the stock its 8th largest position. Arvin Capital Management LP’s holdings in GE HealthCare Technologies were worth $24,927,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at $27,000. Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies in the fourth quarter valued at $27,000. Montag A & Associates Inc. increased its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Wells Fargo & Company cut their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a report on Wednesday, April 29th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $80.21.

Insiders Place Their Bets

In related news, CFO James Saccaro bought 3,310 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were acquired at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Watkin Phoebe L. Yang purchased 1,000 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Up 1.0%

Shares of NASDAQ GEHC opened at $65.18 on Friday. The company’s 50-day simple moving average is $66.32 and its 200-day simple moving average is $75.20. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The firm has a market cap of $29.65 billion, a price-to-earnings ratio of 15.59, a price-to-earnings-growth ratio of 1.47 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the business earned $1.01 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.